
News|Articles|June 22, 2026
Faricimab (Vabysmo® , Roche Products Ltd) for visual impairment due to macular oedema secondary to retinal vein occlusion: An educational supplement
This is a promotional supplement commissioned by Roche Products Limited.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Beyond anti-VEGF: The next wave in retinal therapy
2
Trehalose-hyaluronate combination aids tear film after eyelid surgery
3
ZEISS reports early implantations of AT LUCIA Toric 721P IOL in Europe
4
Demodex blepharitis: Closing the diagnostic gap to improve ocular surface health
5
















